Dennis C. Shrieve,
MD, PhD, FACR, FASTRO
Chair, Department of Radiation Oncology
Languages Spoken: English, French, Spanish
Dennis C. Shrieve, MD, PhD, is the Huntsman Cancer Institute Chair in Cancer Research and chair of the Department of Radiation Oncology at the University of Utah School of Medicine. He is a member of the Experimental Therapeutics Program at the Huntsman Cancer Institute and co-director of the Stereotactic Radiosurgery Program at the University.
Shrieve is board certified by the American Board of Radiology in Radiation Oncology and has primary clinical research interests in adult and pediatric neuro-oncology, pediatric radiation oncology, and stereotactic radiotherapy. His basic research interests include intrinsic radiosensitivity of human tumors, the mechanisms of intrinsic cellular resistance to radiation and chemotherapy, and combined chemotherapy/radiotherapy.
Shrieve serves on the Board of Trustees of the American Board of Radiology and is past-President of the International Stereotactic Radiosurgery Society. He has been listed in Best Doctors in America for over 10 years.
Shrieve received his MD from the University of Miami and his PhD in radiation biophysics from the University of California at Berkeley. He served on the faculties of the University of California, San Francisco, and Harvard Medical School before coming to the University of Utah.
Shrieve is the author or co-author of over 150 articles or book chapters in the medical and scientific literature. He co-editied the book "Human Radiation Injury" in 2010.
Clinical areas of special expertise include pediatric brain tumors, adult brain tumors, stereotactic radiosurgery and treatment of brain metastases.
Clinical Locations
Radiation Oncology
801-581-2396
Fax: (801) 585-2666
Board Certification and Academic Information
| Academic Departments | Radiation Oncology
-
Professor |
| Board Certification | American Board of Radiology (Radiation Oncology) |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.8/ 5
Care provider's explanation of condition/problem
4.8/ 5
Care provider's effort to include me in decisions
4.9/ 5
Wait time at clinic
4.6/ 5
Care provider's concern for questions & worries
4.9/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
Dennis C. Shrieve, MD, PhD, is the Huntsman Cancer Institute Chair in Cancer Research and chair of the Department of Radiation Oncology at the University of Utah School of Medicine. He is a member of the Experimental Therapeutics Program at the Huntsman Cancer Institute and co-director of the Stereotactic Radiosurgery Program at the University.
Shrieve is board certified by the American Board of Radiology in Radiation Oncology and has primary clinical research interests in adult and pediatric neuro-oncology, pediatric radiation oncology, and stereotactic radiotherapy. His basic research interests include intrinsic radiosensitivity of human tumors, the mechanisms of intrinsic cellular resistance to radiation and chemotherapy, and combined chemotherapy/radiotherapy.
Shrieve serves on the Board of Trustees of the American Board of Radiology and is past-President of the International Stereotactic Radiosurgery Society. He has been listed in Best Doctors in America for over 10 years.
Shrieve received his MD from the University of Miami and his PhD in radiation biophysics from the University of California at Berkeley. He served on the faculties of the University of California, San Francisco, and Harvard Medical School before coming to the University of Utah.
Shrieve is the author or co-author of over 150 articles or book chapters in the medical and scientific literature. He co-editied the book "Human Radiation Injury" in 2010.
Clinical areas of special expertise include pediatric brain tumors, adult brain tumors, stereotactic radiosurgery and treatment of brain metastases.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Radiation Oncology
-
Professor |
| Board Certification | American Board of Radiology (Radiation Oncology) |
Research Interests
- Adult and pediatric neuro-oncology
- Pediatric Radiation Oncology
- Conformal radiotherapy and radiosurgery for intracranial tumors of children and adults
- Radiotherapy using altered fractionation in the treatment of pediatric and adult tumors
- Combined chemoradiotherapy
- Genitourinary malignancies
- Intrinsic radiosensitivity of human tumors
- Mechanisms of intrinsic cellular resistance to radiation and chemotherapy
- Role of microenvironmental factors on cellular sensitivity to radiation and to chemotherapeutic agents
- Mechanisms of normal tissue injury and repair following radiotherapy
Education History
| Chief Resident | University of California - San Francisco Radiation Oncology Chief Resident, 1993 |
| Residency | University of California - San Francisco Radiation Oncology Resident, 1992 |
| Internship | University of California - San Francisco Medicine Intern, 1990 |
| Professional Medical | University of Miami School of Medicine Medicine M.D., 1989 |
| Postdoctoral Fellowship | Mount Vernon Hospital Research Postdoctoral Fellow, 1983 |
| Doctoral Training | University of California - Berkeley Radiation Biophysics Ph.D., 1982 |
| Undergraduate | University of California - Berkeley Zoology A.B., 1975 |
Selected Publications - Journal Articles
Journal Article
- Wallner PE, McGeagh AM, Gerdeman AM, Wilson LD, Shrieve DC, Alektiar KM, Hahn SM, Kachnic LA, Jackson VP (2018). Snapshot of a Specialty: Results of the ABR 2016 Radiation Oncology Clinical Practice Analysis. J Am Coll Radiol, 16(4 Pt A), 513-517.
- Tward JD, Poppe MM, Hitchcock YJ, ONeil B, Albertson DJ, Shrieve DC (2018). Demographics, stage distribution, and relative roles of surgery and radiotherapy on survival of persons with primary prostate sarcomas. Cancer Med, 7(12), 6030-6039.
- Burt LM, Shrieve DC, Tward JD (2018). Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database. Adv Radiat Oncol, 3(2), 170-180.
- Ma L, Sahgal A, Nie K, Hwang A, Karotki A, Wang B, Shrieve DC, Sneed PK, McDermott M, Larson DA (2012). Reliability of contour-based volume calculation for radiosurgery. J Neurosurg, 117 Suppl, 203-10.
- Shrieve DC, Colman H (2012). Medulloblastoma: molecular classifications and prognostic associations. Oncology (Williston Park), 26(11), 1097, 1102.
- Cooke EW, Shrieve DC, Tward JD (2011). Clinical versus pathologic staging for prostate adenocarcinoma: how do they correlate? Am J Clin Oncol, 35(4), 364-8.
- Montejo ME, Shrieve DC, Bentz BG, Hunt JP, Buchman LO, Agarwal N, Hitchcock YJ (2011). IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys, 81(5), e845-52.
- Ma L, Petti P, Wang B, Descovich M, Chuang C, Barani IJ, Kunwar S, Shrieve DC, Sahgal A, Larson DA (2011). Apparatus dependence of normal brain tissue dose in stereotactic radiosurgery for multiple brain metastases. J Neurosurg, 114(6), 1580-4.
- Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Junck L, Linette GP, Loeffler JS, Maor MH, Michael M, Moots PL, Morrison T, Mrugala M, Nabors LB, Newton HB, Portnow J, Raizer JJ, Recht L, Shrieve DC, Sills AK Jr, Vrionis FD, Wen PY, National Comprehensive Cancer Network (2011). Central nervous system cancers. J Natl Compr Canc Netw, 9(4), 352-400.
- Wang B, Rassiah-Szegedi P, Zhao H, Huang YJ, Sarkar V, Szegedi M, Kokeny KE, Anker CJ, Shrieve DC, Salter BJ (2011). Initial experience and clinical comparison of two image guidance methods for SBRT treatment: 4DCT versus respiratory-triggered imaging. J Appl Clin Med Phys, 12(3), 3429.
- Rassiah-Szegedi P, Wang B, Szegedi M, Tward J, Zhao H, Huang YJ, Sarkar V, Shrieve D, Salter B (2011). Individualized margins for prostate patients using a wireless localization and tracking system. J Appl Clin Med Phys, 12(3), 3516.
- Ma L, Sahgal A, Cozzi L, Chang E, Shiu A, Letourneau D, Yin FF, Fogliata A, Kaissl W, Hyde D, Laperriere NJ, Shrieve DC, Larson DA (2010). Apparatus-dependent dosimetric differences in spine stereotactic body radiotherapy. Technol Cancer Res Treat, 9(6), 563-74.
- Chen J, Pappas L, Moeller JH, Rankin J, Sharma PK, Bentz BG, Fang LC, Hayes JK, Shrieve DC, Hitchcock YJ (2006). Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy. Head Neck, 29(4), 362-9.
Book
- Shrieve DC, Loeffler JS (October 2010). Human Radiation injury. Philadelphia: Lippincott Williams & Wilkins.
Global Impact
Education History
| Postdoctoral Fellowship | Mount Vernon Hospital Research Postdoctoral Fellow |